Japanese marketing approval for the smartheart TM in place. Exploring marketing opportunities.

Tel Aviv/Zurich, 13 March 2014 – SHL Telemedicine Ltd. (SIX Swiss Exchange:
SHLTN), a leading provider and developer of advanced personal telemedicine solutions,
announced that it has a Japanese PMDA Pre-Market Certification for marketing the
smartheart in Japan. The smartheartTM has received already a marketing approval in
Europe according to the EU Medical Directive (the CE) and the US according to the
American Food and Drug Administration (the FDA).

for more information click here